Instruction for use: Polysaccharide meningococcal vaccine A+C

Dosage form: Lyophilizate for the preparation of solution for intramuscular and subcutaneous administration

Active substance: Vaccinum antimeningococcum

ATX

J07AH01 Meningococcus A antigen polysaccharide purified

Pharmacological group

Vaccines, serums, phages and toxoids

The nosological classification (ICD-10)

A39 Meningococcal infection: Asymptomatic carriage of meningococci; Infection of meningococcal; Meningococcus aureus; The epidemic of meningitis

Composition and release form

1 dose of lyophilized powder for the preparation of an injection of a polysaccharide vaccine for the prevention of meningococcal infection of serogroups A and C contains purified lyophilized polysaccharides of Neisseria meningitidis serogroups A and C of 50 μg, lactose q.s. For lyophilization; In bottles of 1 dose, complete with a solvent in a syringe of 0.5 ml or in bottles of 10, 20 and 50 doses, complete with a solvent in bottles of 5, 10 and 25 ml respectively, in a carton 1 set (1, 20 And 50 doses) or 10 sets (10 doses). The solvent contains sodium chloride 4.15 mg, dibasic sodium phosphate 0.065 mg, monobasic sodium phosphate 0.023 mg, water for injection q.s. Up to 0.5 ml.

Characteristic

Polysaccharide vaccine for prevention of meningococcal infection of serogroups A and C.

Pharmachologic effect

Mode of action - Immunostimulating.

Forms active specific immunity to meningococcus (Neisseria meningitidis) serogroups A and C.

Pharmacodynamics

The vaccine induces immunity (persists for 3 years after vaccination) only against meningitis caused by meningococcus serogroups A and C; Does not provide protection against purulent meningitis of a different etiology: group B meningococci, Haemophilus influenzae, Streptococcus pneumoniae, and others.

Indications of the drug Polysaccharide meningococcal vaccine A+C

Prevention of cerebrospinal meningitis of meningococcal etiology of serogroups A and C (in endemic areas or in the case of an epidemic).

Contraindications

Hypersensitivity, acute infectious diseases, progressive diseases (acute or chronic). Children's age (up to 18 months) during the extra-epidemic period.

Application of pregnancy and breastfeeding

Vaccination during pregnancy and lactation can be carried out in case of high risk of infection (harmlessness of vaccine prevention of meningococcal infection of serogroups A and C in pregnant women is not established).

Side effects

During the first 3 days after vaccination, sometimes (mostly in children than in adults) there is a slight reddening at the injection site, hyperthermia (rapidly passing after taking antipyretics), irritability, weakness.

Dosing and Administration

SC or IM, a single injection to adults or children, starting at 18 months of age. Before use, the lyophilizate vaccine is dissolved using the supplied solvent.

Precautionary measures

Vaccination of infants older than 3 months is possible in case of their contact with persons infected with meningococcus. The entire diluted vaccine is immediately used; The syringe (packaging) after use is destroyed.

Special instructions

When carrying out mass vaccination, needleless injectors can be used.

Storage conditions of the drug Polysaccharide meningococcal vaccine A+C

At a temperature 2-8 °C.

Keep out of the reach of children.

The shelf life of the drug Polysaccharide meningococcal vaccine A+C

3 years.

Do not use beyond the expiration date printed on the package.